COVID19 infection in a patient undergoing treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH) with Ravulizumab

被引：0
|
作者：
Sufana Shikdar
Azra Borogovac
Elabdallah Mohamad
Mohamad Khawandanah
机构：
[1] University of Oklahoma Health Sciences Center,Department of Hematology/Oncology, Stephenson Cancer Center
[2] University of Oklahoma Medical Center (OUMC),Department of Internal Medicine
[3] University of Oklahoma Health Sciences Center,Hematology/Oncology fellow, Department of Medicine, Division of Hematology
来源：
Thrombosis Journal | / 19卷
关键词：
COVID19; Paroxysmal nocturnal hemoglobinuria; Complement inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Chromosomal abnormalities in paroxysmal nocturnal hemoglobinuria (PNH).
    Araten, D
    Bessler, M
    Nafa, K
    Longo, L
    Karadimitris, A
    Freeman, J
    Anastagnopoulous, N
    Beris, P
    Boulad, F
    CastroMalaspina, H
    Chase, A
    Childs, B
    Kutlar, A
    Maziarz, R
    Tsatalas, C
    Weiss, M
    Jhanwar, S
    Luzzatto, L
    BLOOD, 1997, 90 (10) : 2694 - 2694
  • [32] Morphological Spectrum of Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Ghosh, Kanjaksha
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2015, 31 (02) : 314 - 316
  • [33] Ravulizumab in paroxysmal nocturnal hemoglobinuria: a profile of its use
    Kate McKeage
    Katherine Ann Lyseng-Williamson
    Drugs & Therapy Perspectives, 2019, 35 : 405 - 412
  • [34] Ravulizumab in paroxysmal nocturnal hemoglobinuria: a profile of its use
    McKeage, Kate
    Lyseng-Williamson, Katherine Ann
    DRUGS & THERAPY PERSPECTIVES, 2019, 35 (09) : 405 - 412
  • [35] Manifestation of Pancytopenia Associated with COVID-19 as Paroxysmal Nocturnal Hemoglobinuria (PNH) and Aplastic Anemia (AA)
    Aguilar, Jeff Justin
    Dhillon, Vikram
    Balasubramanian, Suresh
    HEMATOLOGY REPORTS, 2024, 16 (01) : 42 - 49
  • [36] Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria
    Stern, Robert M.
    Connell, Nathan T.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10
  • [37] Outcome characteristics of patients with paroxysmal nocturnal hemoglobinuria (PNH): data from the German PNH registry including eculizumab, ravulizumab and untreated patients
    Roth, A.
    Alashkar, F.
    Panse, J.
    Sockel, K.
    Haferlach, T.
    Hubel, K.
    Blau, I. W.
    Platzbecker, U.
    Hochsmann, B.
    Schrezenmeier, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 174 - 174
  • [38] Progressive, purpuric nodules on a patient with aplastic anemia and paroxysmal nocturnal hemoglobinuria (PNH)
    Farid, Yostina
    Schneider, Sarah
    Caraway, Hetty
    Warren, Christine
    Vij, Alok
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB259 - AB259
  • [39] A PATIENT WITH PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA (PNH) WITH AN INHERITED MUTATION IN PIG-A
    ENDO, M
    WARE, RE
    VREEKE, TM
    SINGH, S
    HOWARD, TA
    HOLGUIN, MH
    PARKER, CJ
    BLOOD, 1994, 84 (10) : A555 - A555
  • [40] A Case of Paroxysmal Nocturnal Hemoglobinuria (PNH) in an Obstetric Patient: A South African Perspective
    Laudin, Garrick
    Wium, Lizemarie
    CLINICAL MANAGEMENT ISSUES, 2019, 13 (01) : 1 - 5
12345